Wickerhamomyces anomalus, formerly known as Hansenula anomala, is an opportunistic yeast. Individuals whose immunity is compromised may develop infections due to this pathogen. In 1958, Wang and Schwarz first found it in an infant’s lungs. Since then, cases and outbreaks have happened globally.
A 1996 outbreak affected newborns in an Indian hospital. It showed vulnerable groups could get sick. In 2001, eight adults got infected during a Croatian surgical ICU outbreak. The illness impacted diverse patients. Risk factors were high alkaline blood, low urea levels, extended hospitalization, and Pseudomonas aeruginosa presence.
Recent reports include a 2020 case in India. Hansenula anomala caused a catheter-related bloodstream infection in a leukemic, immune suppressed patient. Early detection & treatment successfully managed the infection. In 2021, Brazil’s oncology hospital reported an outbreak with 24 cases of Hansenula anomala infections in patients getting chemotherapy for blood cancers, and these patients unfortunately passed away.
Hansenula anomala is a type of pathogenic yeast. This round or oblong yeast belongs to the Saccharomycetes class and Saccharomycetaceae family. Its cells can exist alone, in pairs, or in groups. Notably, these yeast cells exhibit many budding patterns. Their forms vary, including oval, round, and paired shapes, and the yeast buds are in branching arrangements.
H anomala can create pseudohyphae. These are chains of connected oval or cylindrical cells. The pseudohyphae help the yeast adapt to its environment. They could also potentially contribute to infections.
Hansenula anomala has a sexual life cycle stage. It produces one to four hat-shaped spores inside a sac like structure called an ascus. This reproductive ability gives the yeast genetic variety and survival advantages.
Hansenula anomala shares about 70% of its genes with the common disease causing Candida albicans. However, it has unique genetic features. Specific genes not found in Candida species help produce special traits like the killer toxin and N-methylphenylalanine pili. The killer toxin is an important virulence factor. It stops the growth of competing yeasts, showing H. anomala‘s ability to dominate its environment.
Hansenula anomala can adapt its metabolism very well. In low oxygen conditions, it produces ethanol & acetic acid. It makes the environment more acidic and increases osmotic pressure. This ability helps the yeast survive in different conditions.
When under osmotic stress, H. anomala makes glycerol, arabinitol, and trehalose. These compounds help the yeast lives in high sugar or high salt environments. The type strain, NRRL Y-366, was isolated from soil in the USA. It is a representative heterothallic strain with various names like CBS 5759, DSM 6766, JCM 3585, NCYC 432, and ATCC 8168.
The fungus Hansenula anomala is an opportunistic microbe that tends to infect people with weak immune systems and those with medical devices like catheters. Its ability to stick to catheter surfaces and form protective biofilm layers makes it hard to treat. These biofilms shield the fungus from the body’s defenses & antifungal medicines. Catheters provide a way for H. anomala to get into the body, allowing infections to spread through the bloodstream and damage different organs, causing inflammation.
H.anomala produces a toxin that stops other yeasts like Candida from growing nearby. It also makes enzymes like phospholipases and proteases, which may help it invades tissues and evade the immune system, increasing its ability to cause disease.
H.anomala is widely found in nature, living in soil, water, plants, fruits, grains, silage, sewage, and warm-blooded animals. People can get infected through contact with contaminated materials or fluids like nutrition solutions, blood products, or dialysis fluids. Breathing in fungal spores or microaspiration of oral secretions are other possible routes. But the fungus does not spread directly between people.
Symptoms of H. anomala infections depend on the location and severity. A common form is fungemia, where the fungus circulates in the blood. Fungemia may cause no symptoms, or it can lead to fever, low blood pressure, and organ failure.
The complex interaction between the body’s defense and H. anomala involves both innate and adaptive immune components. Natural killer cells, equipped with perforin and granzymes, have the capability to eliminate H. anomala. Macrophages contribute to the defense by engulfing and using reactive oxygen species and nitric oxide to destroy the fungus.
Neutrophils, another crucial part of the innate immune system, engulf and destroy H. anomala through hydrogen peroxide and hypochlorous acid production. In the adaptive immune response, B cells make antibodies targeting H. anomala, helping clear it by activating complement and enabling phagocytosis. T cells release cytokines that activate macrophages, boosting the immune response against H. anomala.
Hansenula anomala infections can present with different problems. These can range from nonsymptomatic, even though the fungus is in the blood, to severe infections that spread to many organs. People with H. anomala infection may experience fever, chills, and low blood pressure. These nonspecific, whole-body signs could mean the fungus is in the bloodstream, called fungemia. Skin lesions may also appear as part of the infection.
In severe cases, H. anomala can lead to major organ problems. The infection may progress and affect vital organs, resulting in heart infection, intestinal infection, lung infection, or brain infection. The variety of symptoms shows this yeast’s potential to spread throughout the body, causing localized and widespread complications.
Blood culture is the key technique to identify H. anomala in blood. This yeast grows well on varied media like CHROMagar Candida, malt agar, or Sabouraud dextrose agar. It forms cream, tan, or pink colonies. It is the primary and most common method for detecting the yeast in the bloodstream.
Microscopic analysis can identify H. anomala yeast cells. A cornmeal agar mount or lactophenol cotton blue helps highlight the morphology. They’re different shapes like spheroidal, elongate, ellipsoidal, or cylindrical. The germ tube test is usually negative.
In affected tissues, histopathology shows yeast cells and pseudohyphae. They’re surrounded by inflammatory cells like neutrophils, macrophages, and giant cells.
Biochemical testing can reveal yeasts’ abilities. It shows if they can break down sugars like glucose, sucrose, and sometimes galactose & maltose. The tests also expose carbon sources the yeast uses, like raffinose, ethanol, glycerol, and citrate. Yeasts have a high tolerance to salt and acidity. But they do not produce ethanol when oxygen is present.
Molecular methods like DNA sequencing or MALDI-TOF-MS identify H. anomala‘s species. They look at partial 18S and 26S ribosomal RNA sequences. DNA sequencing of the ITS region or D1/D2 domain of the LSU rRNA gene confirms this. PCR amplification of these regions allows comparison to databases for accurate identification.
Wickerhamomyces anomalus, formerly known as Hansenula anomala, is an opportunistic yeast. Individuals whose immunity is compromised may develop infections due to this pathogen. In 1958, Wang and Schwarz first found it in an infant’s lungs. Since then, cases and outbreaks have happened globally.
A 1996 outbreak affected newborns in an Indian hospital. It showed vulnerable groups could get sick. In 2001, eight adults got infected during a Croatian surgical ICU outbreak. The illness impacted diverse patients. Risk factors were high alkaline blood, low urea levels, extended hospitalization, and Pseudomonas aeruginosa presence.
Recent reports include a 2020 case in India. Hansenula anomala caused a catheter-related bloodstream infection in a leukemic, immune suppressed patient. Early detection & treatment successfully managed the infection. In 2021, Brazil’s oncology hospital reported an outbreak with 24 cases of Hansenula anomala infections in patients getting chemotherapy for blood cancers, and these patients unfortunately passed away.
Hansenula anomala is a type of pathogenic yeast. This round or oblong yeast belongs to the Saccharomycetes class and Saccharomycetaceae family. Its cells can exist alone, in pairs, or in groups. Notably, these yeast cells exhibit many budding patterns. Their forms vary, including oval, round, and paired shapes, and the yeast buds are in branching arrangements.
H anomala can create pseudohyphae. These are chains of connected oval or cylindrical cells. The pseudohyphae help the yeast adapt to its environment. They could also potentially contribute to infections.
Hansenula anomala has a sexual life cycle stage. It produces one to four hat-shaped spores inside a sac like structure called an ascus. This reproductive ability gives the yeast genetic variety and survival advantages.
Hansenula anomala shares about 70% of its genes with the common disease causing Candida albicans. However, it has unique genetic features. Specific genes not found in Candida species help produce special traits like the killer toxin and N-methylphenylalanine pili. The killer toxin is an important virulence factor. It stops the growth of competing yeasts, showing H. anomala‘s ability to dominate its environment.
Hansenula anomala can adapt its metabolism very well. In low oxygen conditions, it produces ethanol & acetic acid. It makes the environment more acidic and increases osmotic pressure. This ability helps the yeast survive in different conditions.
When under osmotic stress, H. anomala makes glycerol, arabinitol, and trehalose. These compounds help the yeast lives in high sugar or high salt environments. The type strain, NRRL Y-366, was isolated from soil in the USA. It is a representative heterothallic strain with various names like CBS 5759, DSM 6766, JCM 3585, NCYC 432, and ATCC 8168.
The fungus Hansenula anomala is an opportunistic microbe that tends to infect people with weak immune systems and those with medical devices like catheters. Its ability to stick to catheter surfaces and form protective biofilm layers makes it hard to treat. These biofilms shield the fungus from the body’s defenses & antifungal medicines. Catheters provide a way for H. anomala to get into the body, allowing infections to spread through the bloodstream and damage different organs, causing inflammation.
H.anomala produces a toxin that stops other yeasts like Candida from growing nearby. It also makes enzymes like phospholipases and proteases, which may help it invades tissues and evade the immune system, increasing its ability to cause disease.
H.anomala is widely found in nature, living in soil, water, plants, fruits, grains, silage, sewage, and warm-blooded animals. People can get infected through contact with contaminated materials or fluids like nutrition solutions, blood products, or dialysis fluids. Breathing in fungal spores or microaspiration of oral secretions are other possible routes. But the fungus does not spread directly between people.
Symptoms of H. anomala infections depend on the location and severity. A common form is fungemia, where the fungus circulates in the blood. Fungemia may cause no symptoms, or it can lead to fever, low blood pressure, and organ failure.
The complex interaction between the body’s defense and H. anomala involves both innate and adaptive immune components. Natural killer cells, equipped with perforin and granzymes, have the capability to eliminate H. anomala. Macrophages contribute to the defense by engulfing and using reactive oxygen species and nitric oxide to destroy the fungus.
Neutrophils, another crucial part of the innate immune system, engulf and destroy H. anomala through hydrogen peroxide and hypochlorous acid production. In the adaptive immune response, B cells make antibodies targeting H. anomala, helping clear it by activating complement and enabling phagocytosis. T cells release cytokines that activate macrophages, boosting the immune response against H. anomala.
Hansenula anomala infections can present with different problems. These can range from nonsymptomatic, even though the fungus is in the blood, to severe infections that spread to many organs. People with H. anomala infection may experience fever, chills, and low blood pressure. These nonspecific, whole-body signs could mean the fungus is in the bloodstream, called fungemia. Skin lesions may also appear as part of the infection.
In severe cases, H. anomala can lead to major organ problems. The infection may progress and affect vital organs, resulting in heart infection, intestinal infection, lung infection, or brain infection. The variety of symptoms shows this yeast’s potential to spread throughout the body, causing localized and widespread complications.
Blood culture is the key technique to identify H. anomala in blood. This yeast grows well on varied media like CHROMagar Candida, malt agar, or Sabouraud dextrose agar. It forms cream, tan, or pink colonies. It is the primary and most common method for detecting the yeast in the bloodstream.
Microscopic analysis can identify H. anomala yeast cells. A cornmeal agar mount or lactophenol cotton blue helps highlight the morphology. They’re different shapes like spheroidal, elongate, ellipsoidal, or cylindrical. The germ tube test is usually negative.
In affected tissues, histopathology shows yeast cells and pseudohyphae. They’re surrounded by inflammatory cells like neutrophils, macrophages, and giant cells.
Biochemical testing can reveal yeasts’ abilities. It shows if they can break down sugars like glucose, sucrose, and sometimes galactose & maltose. The tests also expose carbon sources the yeast uses, like raffinose, ethanol, glycerol, and citrate. Yeasts have a high tolerance to salt and acidity. But they do not produce ethanol when oxygen is present.
Molecular methods like DNA sequencing or MALDI-TOF-MS identify H. anomala‘s species. They look at partial 18S and 26S ribosomal RNA sequences. DNA sequencing of the ITS region or D1/D2 domain of the LSU rRNA gene confirms this. PCR amplification of these regions allows comparison to databases for accurate identification.
Wickerhamomyces anomalus, formerly known as Hansenula anomala, is an opportunistic yeast. Individuals whose immunity is compromised may develop infections due to this pathogen. In 1958, Wang and Schwarz first found it in an infant’s lungs. Since then, cases and outbreaks have happened globally.
A 1996 outbreak affected newborns in an Indian hospital. It showed vulnerable groups could get sick. In 2001, eight adults got infected during a Croatian surgical ICU outbreak. The illness impacted diverse patients. Risk factors were high alkaline blood, low urea levels, extended hospitalization, and Pseudomonas aeruginosa presence.
Recent reports include a 2020 case in India. Hansenula anomala caused a catheter-related bloodstream infection in a leukemic, immune suppressed patient. Early detection & treatment successfully managed the infection. In 2021, Brazil’s oncology hospital reported an outbreak with 24 cases of Hansenula anomala infections in patients getting chemotherapy for blood cancers, and these patients unfortunately passed away.
Hansenula anomala is a type of pathogenic yeast. This round or oblong yeast belongs to the Saccharomycetes class and Saccharomycetaceae family. Its cells can exist alone, in pairs, or in groups. Notably, these yeast cells exhibit many budding patterns. Their forms vary, including oval, round, and paired shapes, and the yeast buds are in branching arrangements.
H anomala can create pseudohyphae. These are chains of connected oval or cylindrical cells. The pseudohyphae help the yeast adapt to its environment. They could also potentially contribute to infections.
Hansenula anomala has a sexual life cycle stage. It produces one to four hat-shaped spores inside a sac like structure called an ascus. This reproductive ability gives the yeast genetic variety and survival advantages.
Hansenula anomala shares about 70% of its genes with the common disease causing Candida albicans. However, it has unique genetic features. Specific genes not found in Candida species help produce special traits like the killer toxin and N-methylphenylalanine pili. The killer toxin is an important virulence factor. It stops the growth of competing yeasts, showing H. anomala‘s ability to dominate its environment.
Hansenula anomala can adapt its metabolism very well. In low oxygen conditions, it produces ethanol & acetic acid. It makes the environment more acidic and increases osmotic pressure. This ability helps the yeast survive in different conditions.
When under osmotic stress, H. anomala makes glycerol, arabinitol, and trehalose. These compounds help the yeast lives in high sugar or high salt environments. The type strain, NRRL Y-366, was isolated from soil in the USA. It is a representative heterothallic strain with various names like CBS 5759, DSM 6766, JCM 3585, NCYC 432, and ATCC 8168.
The fungus Hansenula anomala is an opportunistic microbe that tends to infect people with weak immune systems and those with medical devices like catheters. Its ability to stick to catheter surfaces and form protective biofilm layers makes it hard to treat. These biofilms shield the fungus from the body’s defenses & antifungal medicines. Catheters provide a way for H. anomala to get into the body, allowing infections to spread through the bloodstream and damage different organs, causing inflammation.
H.anomala produces a toxin that stops other yeasts like Candida from growing nearby. It also makes enzymes like phospholipases and proteases, which may help it invades tissues and evade the immune system, increasing its ability to cause disease.
H.anomala is widely found in nature, living in soil, water, plants, fruits, grains, silage, sewage, and warm-blooded animals. People can get infected through contact with contaminated materials or fluids like nutrition solutions, blood products, or dialysis fluids. Breathing in fungal spores or microaspiration of oral secretions are other possible routes. But the fungus does not spread directly between people.
Symptoms of H. anomala infections depend on the location and severity. A common form is fungemia, where the fungus circulates in the blood. Fungemia may cause no symptoms, or it can lead to fever, low blood pressure, and organ failure.
The complex interaction between the body’s defense and H. anomala involves both innate and adaptive immune components. Natural killer cells, equipped with perforin and granzymes, have the capability to eliminate H. anomala. Macrophages contribute to the defense by engulfing and using reactive oxygen species and nitric oxide to destroy the fungus.
Neutrophils, another crucial part of the innate immune system, engulf and destroy H. anomala through hydrogen peroxide and hypochlorous acid production. In the adaptive immune response, B cells make antibodies targeting H. anomala, helping clear it by activating complement and enabling phagocytosis. T cells release cytokines that activate macrophages, boosting the immune response against H. anomala.
Hansenula anomala infections can present with different problems. These can range from nonsymptomatic, even though the fungus is in the blood, to severe infections that spread to many organs. People with H. anomala infection may experience fever, chills, and low blood pressure. These nonspecific, whole-body signs could mean the fungus is in the bloodstream, called fungemia. Skin lesions may also appear as part of the infection.
In severe cases, H. anomala can lead to major organ problems. The infection may progress and affect vital organs, resulting in heart infection, intestinal infection, lung infection, or brain infection. The variety of symptoms shows this yeast’s potential to spread throughout the body, causing localized and widespread complications.
Blood culture is the key technique to identify H. anomala in blood. This yeast grows well on varied media like CHROMagar Candida, malt agar, or Sabouraud dextrose agar. It forms cream, tan, or pink colonies. It is the primary and most common method for detecting the yeast in the bloodstream.
Microscopic analysis can identify H. anomala yeast cells. A cornmeal agar mount or lactophenol cotton blue helps highlight the morphology. They’re different shapes like spheroidal, elongate, ellipsoidal, or cylindrical. The germ tube test is usually negative.
In affected tissues, histopathology shows yeast cells and pseudohyphae. They’re surrounded by inflammatory cells like neutrophils, macrophages, and giant cells.
Biochemical testing can reveal yeasts’ abilities. It shows if they can break down sugars like glucose, sucrose, and sometimes galactose & maltose. The tests also expose carbon sources the yeast uses, like raffinose, ethanol, glycerol, and citrate. Yeasts have a high tolerance to salt and acidity. But they do not produce ethanol when oxygen is present.
Molecular methods like DNA sequencing or MALDI-TOF-MS identify H. anomala‘s species. They look at partial 18S and 26S ribosomal RNA sequences. DNA sequencing of the ITS region or D1/D2 domain of the LSU rRNA gene confirms this. PCR amplification of these regions allows comparison to databases for accurate identification.

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
